37 results about "Clinical evidence" patented technology

A system and related techniques automatically generate optimized, best-match or sufficient assignments of care providers, such as physicians, nurses or technicians, to a patient based on clinical evidence, documentation, workload, infectious status and other factors. In embodiments, the patient's chart or other clinical record may be accessed by a rules-based engine configured with rules which relate a patient's clinical status and needs to the qualifications, certifications, capabilities and skills of care providers and select the care provider best qualified to service that patient's clinical requirements. The pool of available care providers may for example be ascertained from personnel systems recording staff schedules and estimated workload, while the qualifications of each provider indicating the categories of patient care and support that provider is qualified to provide may be accessed from a provider data store. For instance, nurses or technicians trained or certified in acute, emergency or surgical care may be identified for assignment to high acuity patients, or those presenting special or advanced care demands. According to the invention in a further regard, the provider's potential infectious exposure to other patients or from other sources may be screened to prevent that provider from being assigned to immune-compromised or other patients. Embodiments of the invention may present floor managers with a graphical display of available providers and generated assignments, which in embodiments the manager may override at their clinical discretion. Because patient needs are automatically aligned with provider capabilities, availability and other factors, the errors, oversights and inefficiencies of manual or informal assignment systems are avoided and better health care delivery can be realized.

The invention discloses a multi-center knowledge graph joint decision support method and system, which utilizes a medical knowledge graph technology and a block chain technology to realize local semantic reasoning and on-chain result summarizing of clinical data through a mode of combining a local knowledge graph and an on-chain synchronous graph, and therefore, under the condition that original medical data is not out of a hospital, interpretable clinical decision support containing complete clinical evidences of the patient is given based on deductive reasoning and evidence-based medicine by integrating fragmented cross-institution medical data of the patient through the knowledge graph technology. Patient identity information is subjected to anonymous comparison, complete encryption of data in an out-of-hospital link and a matching link is guaranteed, triple node structure information is subjected to coding mapping and asymmetric encryption, the safety of the data in the transmission process is guaranteed, only a participating center with permission can decrypt the data, and the data security and privacy guarantee in the multi-center joint reasoning process are effectively ensured.

Care provider assignments to a patient may be automatically generated based on clinical evidence, documentation, workload, infectious status and other factors. The patient's chart may be accessed by a rules-based engine configured with rules to relate a patient's clinical status and needs to qualifications, certifications, capabilities and skills of care providers to select the care provider best qualified to assign to the patient. For instance, care providers having specialized training may be identified for assignment to patients presenting with specialized needs. Graphical displays of available providers may be displayed to and overridden by a manager. Because patient needs are automatically aligned with provider capabilities, availability and other factors, the errors, oversights and inefficiencies of manual or informal assignment systems are avoided and better health care delivery can be realized.

The invention discloses a compound composition of traditional Chinese medicine granules for regulating liver regeneration and prevention and treatment methods for chronic liver diseases by using the compound alone or in combination with antiviral medicine. The medicine is composed of: 5-30 parts of prepared Chinese foxglove root, 5-30 parts of virgate wormwood, 3-9 parts of turmeric, 3-12 parts of licorice, 3-15 parts of schisandra fruit, 5-15 parts of underleaf pearl, 5-30 parts of diffusa , 5-30 parts of poria, 5-30 parts of coix seed, 5-30 parts of salvia fruit, 1-10 parts of curcuma rhizome, 3-12 parts of dodder, and 5-15 parts of mistletoe For people suffering from chronic liver diseases (drug-induced liver disease, alcoholic or non-alcoholic fatty liver disease, autoimmune liver disease, viral hepatitis, etc.) which have high risk of liver failure, liver cirrhosis, and liver cancer, and people suffering from liver cancer or people after liver cancer surgery, clinical and experimental evidences show that the traditional Chinese medicine granules have synergies of regulation of liver regeneration and anti-virus, anti-liver injury, anti-liver fibrosis, and liver cancer prevention, and a relatively high level of clinical evidence based medicine evidences are obtained.

The invention relates to the field of animal medicines, and particularly relates to a compound propolis combination for treating swine erysipelas. The compound propolis combination is prepared by mixing the following components in parts by weight: 15 to 35 parts of propolis, 15 to 35 parts of rheum officinale, 15 to 35 parts of burdock, 15 to 35 parts of herba taching, 15 to 45 parts of gentiana scabra bge, 15 to 35 parts of cortex moutan, 15 to 40 parts of liquorice, 15 to 45 parts of cape jasmine fruit, 15 to 45 parts of pericarpium citri reticulatae, and 15 to 45 parts of fructus forsythia. The compound propolis combination has the beneficial effects of being reasonable in composition and simple to prepare, being free from toxic and side effects, pollution, drug residues and tolerance, achieving high biological availability as being subjected to superfine grinding, having a greatly remarkable curative effect, and having a special effect on treating the swine erysipelas according to clinical evidence.

Computer based methods, systems, and computer readable media for intelligently accessing various types of pharmaceutical information in a content repository and ranking drugs at the variant level, gene level, and pathway level. In some cases, drugs that target the same gene, gene variant, or biological pathway may be ranked based upon in vitro, pre-clinical, clinical, or post-clinical evidence. To determine ranking of a plurality of drugs, information pertaining to drug administration is analyzed for the drugs. For a plurality of drugs, attributes corresponding to the drug are determined, wherein the attributes include a variant or a gene targeted by the drug, and a biological pathway comprising the targeted variant or gene. The plurality of drugs are ranked according to a drug effectiveness score based on one or more of a determined efficacy, potency, or toxicity.

Relating to the field of animal medicines, the invention provides a compound propolis composition for promoting pig growth and fattening as well as its preparation method. The composition and its preparation method in the invention are shown as the following: (1) respectively subjecting each component in a formula to superfine comminution and then to sieving through a sieve of 700 meshes; (2) weighing, by weight, 15-35 parts of propolis, 10-30 parts of gelsmium elegans, 10-45 parts of scorch-fried three immortals, and 15-40 parts of dried orange peels, and mixing them for 5-10min to a uniform state; (3) weighing, by weight, 15-35 parts of rhizoma atractylodis, 10-35 parts of betel nuts, 10-35 parts of licorice, 15-40 parts of dried ginger, and 15-35 parts of radix astragali, and mixing them for 5-10min to a uniform state; and (4) combining the compositions prepared in step (2) and (3), and continuing to mixing them for 10-15min to a uniform state, thus obtaining the compound propolis composition. The compound propolis composition of the invention has the advantages of reasonable formula, simple preparation, no toxic or side effect, no pollution, no medicine residue, no drug resistance, superfine comminution, high bioavailability, and very obvious curative effect. There is clinical evidence that the compound propolis composition in the invention has specific efficacy in promoting growth and fattening of livestock.

Computerized systems and methods identify deficiencies in patient data that may impact payment for services rendered to a patient and facilitates collection / correction of patient data to address the deficiencies. The deficiencies occur in two main situations: (1) a physician has confirmed a diagnosis that impacts payment but the patient data does not satisfy clinical evidence, direct evidence, and treatment requirements to support the diagnosis; and (2) the patient data satisfies clinical evidence, direct evidence, and treatment requirements to support a diagnosis but a physician has not confirmed the diagnosis. When a deficiency is identified, an electronic notice is generated and delivered over a communication network to a clinician computing device. The notice may provide the clinician access to a user interface that allows the clinician to enter additional information or clarify information in the patient data to address the deficiency.

A guidance system for the treatment and medication of immune checkpoint inhibitors, including an interpretation system for biomarkers related to immune checkpoint inhibitors and its construction method, a medication guidance adaptation method, a device, and a storage medium, wherein the construction method of the interpretation system includes: obtaining public Data resources, including biomarker information related to the treatment of tumor immune checkpoint inhibitors; screening and classification of public data resources to determine the key fields and attributes of the information to be entered into the interpretation system; immune checkpoint inhibition Classify the drug-related clinical evidence information; establish the structural framework of the interpretation system; enter the key field information into the corresponding field position of the interpretation system structural framework according to the unified standardized input rules. The invention solves the problem of inaccurate medication guidance due to scattered data, incomplete data collection, cumbersome query procedures, and no priority in drug recommendation for immune checkpoint inhibitors in the process of medication guidance for immune checkpoint inhibitors.

The invention discloses a traditional Chinese medicine for treating chronic cardiac insufficiency, sick sinus syndrome, ischemic angina pectoris, coronary heart disease and the like, and a preparation method thereof. When the traditional Chinese medicine disclosed by the invention is used for clinical evidence, for deficiency of the heart and kidney-yin and stagnation of heart meridian by differentiation of symptoms and signs of traditional Chinese medicine, the total effective rate for treating congestive heart failure is 88.89%, the total effective rate for treating sick sinus syndrome is 85%, and the total effective rate for treating coronary heart disease caused angina pectoris is 90%. The traditional Chinese medicine is a multi-target good medicine convenient and easy to use for heart, and has conformance to the integral function of the heart. The invention is characterized in that the traditional Chinese medicine is a new medicine which is triggered by symptoms of disease, has a compliance mode of action, is capable of better adjusting the continuous coupling function of the heart, and is favorable to the comprehensive recovery and reconstruction of the integral function of the heart. The medicament disclosed by the invention has the following characteristics of exciting the pacemaker when the pacemaker is weak, strengthening the cardiac efficiency when the myocardial contractive power is weak, improving microcirculation and promoting tissue reconstruction and function recovery when the coronary flow is small, and the like, and the medicament is suitable for all kinds of heart diseases and favorable to comprehensive and integral function recovery of the heart.

The invention discloses a compound composition of traditional Chinese medicine granules for regulating liver regeneration and prevention and treatment methods for chronic liver diseases by using the compound alone or in combination with antiviral medicine. The medicine is composed of: 5-30 parts of prepared Chinese foxglove root, 5-30 parts of virgate wormwood, 3-9 parts of turmeric, 3-12 parts of licorice, 3-15 parts of schisandra fruit, 5-15 parts of underleaf pearl, 5-30 parts of diffusa , 5-30 parts of poria, 5-30 parts of coix seed, 5-30 parts of salvia fruit, 1-10 parts of curcuma rhizome, 3-12 parts of dodder, and 5-15 parts of mistletoe For people suffering from chronic liver diseases (drug-induced liver disease, alcoholic or non-alcoholic fatty liver disease, autoimmune liver disease, viral hepatitis, etc.) which have high risk of liver failure, liver cirrhosis, and liver cancer, and people suffering from liver cancer or people after liver cancer surgery, clinical and experimental evidences show that the traditional Chinese medicine granules have synergies of regulation of liver regeneration and anti-virus, anti-liver injury, anti-liver fibrosis, and liver cancer prevention, and a relatively high level of clinical evidence based medicine evidences are obtained.

The invention relates to a compound propolis combination for treating ox influenza. The compound propolis combination is prepared by mixing the following components in parts by weight: 15 to 35 parts of propolis, 15 to 35 parts of asarum, 15 to 35 parts of radix paeoniae rubra, 15 to 35 parts of artemisia capillaries, 15 to 45 parts of radix bupleuri, 15 to 35 parts of pinellia ternate, 15 to 40 parts of liquorice, 15 to 45 parts of pericarpium citri reticulatae, 15 to 45 parts of fructus aurantii, and 15 to 45 parts of notopterygium root. The compound propolis combination has the beneficial effects of being reasonable in composition and simple to prepare, being free from toxic and side effects, pollution, drug residues and tolerance, achieving high biological availability as being subjected to superfine grinding, having a greatly remarkable curative effect, and having a special effect on treating the ox influenza according to clinical evidence.

The invention belongs to the technical field of traditional Chinese medicine preparation, and relates to a traditional Chinese medicine composition for preventing and treating postpartum urinary retention and a preparation method and application thereof. The traditional Chinese medicine composition includes the following components according to parts by weight: 3-30 parts of ginger, 3-30 parts of scallion white, 0.5-5 parts of fine salt, 2-30 parts of raw astragalus powder, 2-30 parts of Poria powder , Motherwort powder 2‑30 servings. Applying traditional Chinese medicine to the umbilicus for half an hour has a significant effect on preventing postpartum urinary retention, and greatly reduces the incidence of urinary retention. Practical, easy to operate, shortening the hospitalization time of patients, and reducing the occurrence of postoperative urinary tract infection and postpartum hemorrhage; it provides reliable clinical evidence for promoting the application of traditional Chinese medicine to Shenque acupoint on the umbilicus to prevent postpartum urinary retention, and has been popularized by clinical and basic medical institutions. use value.

The invention relates to a compound combination made from pure traditional Chinese medicines and used for treating henpox. The compound combination is prepared by mixing the following components in parts by weight: 15 to 35 parts of houttuynia cordata, 1 to 3 parts of calculus bovis factitious, 1 to 2 parts of venenum bufonis, 15 to 35 parts of borneol, 10 to 30 parts of boswellia carterii, 10 to 30 parts of myrrh, and 15 to 35 parts of rhizoma coptidis. The compound combination has the beneficial effects of being reasonable in composition and simple to prepare, being free from toxic and side effects, pollution, drug residues and tolerance, achieving high biological availability as being subjected to superfine grinding, having a greatly remarkable curative effect, and having a special effect on treating the henpox according to clinical evidence.

Computerized systems and methods identify deficiencies in patient data that may impact payment for services rendered to a patient and facilitates collection / correction of patient data to address the deficiencies. The deficiencies occur in two main situations: (1) a physician has confirmed a diagnosis that impacts payment but the patient data does not satisfy clinical evidence, direct evidence, and treatment requirements to support the diagnosis; and (2) the patient data satisfies clinical evidence, direct evidence, and treatment requirements to support a diagnosis but a physician has not confirmed the diagnosis. When a deficiency is identified, an electronic notice is generated and delivered over a communication network to a clinician computing device. The notice may provide the clinician access to a user interface that allows the clinician to enter additional information or clarify information in the patient data to address the deficiency.